Discovery Chemistry Congress

Venue: Holiday Inn Munich City Center

Location: Munich, Germany

Event Date/Time: Mar 19, 2013 End Date/Time: Mar 20, 2013
Report as Spam


Previous problems with drug discovery led to considerable investment by the pharmaceutical industry, in combinatorial and discovery chemistry.  This conference will integrate the latest structural chemistry with innovative discovery-driven technologies.  Taking place in Munich for the second year running, speakers will concentrate on the most important aspects of discovery stages for effective drug design and refinement.  

In the current economic climate there is increasing global competitiveness and financial pressure, therefore, this conference aims to explore the options available to maximise the success of drug discovery and development.

Our speakers have collaborated to provide four accessible tracks:

  • Fragment-based Lead Discovery
  • Targeting Protein-protein Interactions
  • Formulation & Solubility
  • Chemical Biology

The tracks offered work synergistically to overcome the challenges of drug delivery in a completely new way.  Select Biosciences hopes to help delegates convert this expensive, challenging and inefficient process into a more accessible and affordable one.

Keynote Speakers:

Roderic Hubbard, Professor, University of York

Barry Potter, Professor, University of Bath

Helena Danielson, Professor, Uppsala University

Mark Bradley, Professor/Principal Investigator, University of Edinburgh

Jennifer Laurence, Associate Professor, University of Kansas

Sven Stegemann, Director of Pharmaceutical Business Development, Pfizor

Andrei Gartel, Associate Professor, University of Illinois at Chicago

Arthur Olson, Professor, The Scripps Research Institute

Hiroaki Suga, Professor, The University of Tokyo

David Jones, Chair of Biomaterial Science and Director of Education, Queen's University of Belfast


Hochstr. 3